Maia Fertility
PrivateLast Round
Strategic
Jul 30, 2026
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Maia Fertility is a biotechnology company that develops a proprietary sustained-release enzyme platform, Ferizyme™, to improve reproductive efficiency in mammals.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Maia Fertility Comparables
Compare Maia Fertility with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vytelle | 67% | |
| Parnell Veterinary Pharmaceuticals | 63% | |
| URUS Group | 62% | |
Maia Fertility Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jul 30, 2026 |
Maia Fertility Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Big Idea Ventures | Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 30, 2026
Led by Big Idea Ventures
Maia Fertility Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Maia Fertility's valuation, stock price, and market status.